This is a draft version - Page is not published

Financing, Equity Capital Markets

Fulcrum Therapeutics, Inc.

01/23
|
$125.0 Million
Piper Sandler served as bookrunner for Fulcrum Therapeutics, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma